Park West Asset Management’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-170,669
Closed -$11.3M 70
2016
Q3
$11.3M Sell
170,669
-9,331
-5% -$581K 1.03% 30
2016
Q2
$10.2M Hold
180,000
1.03% 33
2016
Q1
$10.5M Buy
180,000
+69,674
+63% +$3.7M 0.99% 31
2015
Q4
$6.49M Sell
110,326
-1,097
-1% -$64.7K 0.7% 40
2015
Q3
$6.37M Sell
111,423
-42,410
-28% -$3.41M 0.58% 49
2015
Q2
$13.9M Buy
153,833
+19,217
+14% +$1.66M 1.29% 26
2015
Q1
$13M Buy
134,616
+2,364
+2% +$218K 1.89% 21
2014
Q4
$11.6M Buy
132,252
+12,098
+10% +$1.04M 1.84% 21
2014
Q3
$11M Buy
120,154
+16,000
+15% +$1.73M 1.62% 20
2014
Q2
$12M Buy
104,154
+7,501
+8% +$889K 1.57% 22
2014
Q1
$11.7M Sell
96,653
-5,000
-5% -$656K 1.33% 23
2013
Q4
$12.8M Buy
101,653
+4,982
+5% +$598K 1.62% 22
2013
Q3
$10.5M Buy
96,671
+6,988
+8% +$681K 1.56% 19
2013
Q2
$7.56M Buy
+89,683
New +$7.44M 0.89% 37

Other funds holding TRIB

Park West Asset Management's TRIB Position: Q4 2016 in Review

Park West Asset Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 170,669 shares — an estimated $11.3M sold.

Park West Asset Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $13.9M in Q2 2015. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Park West Asset Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Park West Asset Management sold 170,669 Trinity Biotech shares in Q4 2016, an estimated $11.3M.
  • Park West Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Park West Asset Management's Trinity Biotech position peaked at $13.9M in Q2 2015.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Park West Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.